Search Results for keywords:"scientific review officers"

The National Institute on Deafness and Other Communication Disorders announced a closed meeting for the Special Emphasis Panel focusing on clinical trials and hearing disorders. The meeting is scheduled for January 15, 2025, from 2:30 p.m. to 4:30 p.m. and will be held virtually. The purpose of the meeting is to review and evaluate cooperative agreement applications, and it is closed to the public to protect confidential information. Individuals involved with the meeting include scientific review officers, and notice was filed with the Federal Register on December 18, 2024.

The National Eye Institute announced a series of closed virtual meetings to review grant applications related to vision research. These meetings will take place from April 1 to May 1, 2025, and will discuss various types of grants, including those for vision research, clinical trials, and small business innovations. The meetings will be conducted virtually and are closed to protect confidential information. For more details, interested parties can contact the listed scientific review officers via email.

The National Institute of Biomedical Imaging and Bioengineering is announcing closed meetings for reviewing grant applications. The meetings will take place virtually on specific dates in April 2025 and are not open to the public to protect confidential information. Several committees will meet to discuss different topics, including the SBIR/STTR Review and the Brain Initiative RFA Review. Contact details for scientific review officers involved in the meetings are also provided.

In accordance with the Federal Advisory Committee Act, the National Institutes of Health (NIH) announced that several meetings of the Center for Scientific Review will be held virtually. These meetings, taking place between March 19 and March 24, 2021, are closed to the public due to the sensitive nature of the discussions, which include evaluating grant applications and potential disclosure of confidential materials. The subject matter of the meetings ranges from drug discovery and neurodegenerative disorders to HIV/AIDS prevention and treatment, with various scientific review officers assigned to manage the sessions. These sessions aim to review and evaluate various grant proposals, ensuring that personal privacy and proprietary information remain protected.

The National Cancer Institute, part of the National Institutes of Health, has announced several upcoming meetings. These meetings, scheduled between January and March 2025, are intended to evaluate grant applications and contract proposals related to cancer research. The meetings will be closed to the public to protect confidential information and personal privacy. Each meeting will take place virtually, and further details, including contact information for scientific review officers, are provided for each session.

The National Institutes of Health announced several closed meetings of their committees where they will review and evaluate grant applications. These meetings will take place from March 24 to April 4, 2025, and they are closed to the public to protect confidential information and personal privacy. They will be held virtually from the NIH in Bethesda, Maryland. During these sessions, scientific review officers will oversee discussions that may include sensitive topics such as trade secrets or personal data related to grant applicants.

The Center for Scientific Review under the National Institutes of Health announced notice of several closed meetings set to occur from March 2-5, 2021. These meetings are being closed to the public to protect confidential trade secrets or personal privacy in the discussions about grant applications. Committees will review topics ranging from infectious disease epidemiology to novel genomic technology development and neurodevelopment. Contact information for the scientific review officers responsible for each meeting is provided in the announcement.

The National Institute of Neurological Disorders and Stroke (NINDS) has scheduled several meetings to discuss grant applications and cooperative agreements. These meetings are part of a review process and will be closed to the public to protect confidential and personal information. The meetings, occurring from April 1 to April 4, 2025, will be conducted virtually. Contact information for the scientific review officers overseeing each meeting is also provided.

The Center for Scientific Review is holding a series of closed meetings to evaluate grant applications, as per the Federal Advisory Committee Act. These meetings, scheduled for early March 2021, will discuss sensitive information, such as trade secrets and personal data, which warrant privacy. Meetings will take place virtually at the National Institutes of Health in Bethesda, MD, and cover diverse topics including fellowships in genetics, drug discovery, and cancer research. Contact details for various Scientific Review Officers involved are provided for those needing more information.

The National Heart, Lung, and Blood Institute has announced two upcoming meetings that will be closed to the public due to the confidential nature of discussions, which include sensitive information about grant applications. The first meeting, focused on a Program Project Grant Review, will take place on March 18, 2021, and the second meeting, centered on Blood Brain Barrier research, is scheduled for March 29, 2021. Both meetings will occur virtually at the National Institutes of Health in Bethesda, MD. The meetings will be handled by scientific review officers Susan Wohler Sunnarborg and Michael P. Reilly.